Free Newsletter
SPOTLIGHT: Study: Diabetics should take statins
Free newsletter via e-mail
Tools
For the second time this week, statins are being trumpeted for a new population. This time, it's diabetics who should be taking the cholesterol-lowering drugs; researchers found that deaths among diabetics fell by 9 percent with each statin-spawned step reduction in cholesterol. Report
More stories about Statins
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: